These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31075813)

  • 1. Introducing the New COPD Pocket Consultant Guide App: Can A Digital Approach Improve Care? A Statement of the COPD Foundation.
    Thomashow B; Crapo JD; Drummond MB; Han MK; Kalhan R; Malanga E; Malanga V; Mannino DM; Rennard S; Sciurba FC; Willard KS; Wise R; Yawn B
    Chronic Obstr Pulm Dis; 2019 Jul; 6(3):210-220. PubMed ID: 31075813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The COPD Foundation Pocket Consultant Guide.
    Thomashow B; Crapo J; Yawn B; McIvor A; Cerreta S; Walsh J; Mannino D; Rennard S
    Chronic Obstr Pulm Dis; 2014 May; 1(1):83-87. PubMed ID: 28848814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2017 Update to the COPD Foundation COPD Pocket Consultant Guide.
    Yawn BB; Thomashaw B; Mannino DM; Han MK; Kalhan R; Rennard S; Cerrata S; Crapo JD; Wise R
    Chronic Obstr Pulm Dis; 2017 Jul; 4(3):177-185. PubMed ID: 28848929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, recommendations of the COPD Foundation.
    Rennard S; Thomashow B; Crapo J; Yawn B; McIvor A; Cerreta S; Walsh J; Mannino D
    COPD; 2013 Jun; 10(3):378-89. PubMed ID: 23713598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
    Mittal R; Chhabra SK
    COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.
    Bollmeier SG; Seaton TL; Prosser TR; Chou YT; Reckenberg K; Hahn B; Stanford RH; Ray R
    J Am Pharm Assoc (2003); 2019; 59(4):479-488.e1. PubMed ID: 31126830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
    Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.
    Pasquale MK; Xu Y; Baker CL; Zou KH; Teeter JG; Renda AM; Davis CC; Lee TC; Bobula J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():111-21. PubMed ID: 26834468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of symptom and risk assessment methods among patients with chronic obstructive pulmonary disease.
    Zhang R; Tan X; He Q; Chen Q; Gai J; Wei J; Wang Y
    Chin Med J (Engl); 2014; 127(14):2594-8. PubMed ID: 25043073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent updates in chronic obstructive pulmonary disease.
    Garvey C
    Postgrad Med; 2016; 128(2):231-8. PubMed ID: 26560514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease assessment test: usefulness for monitoring recovery and predicting poor course of disease after exacerbations.
    Pulido Herrero E; García Gutiérrez S; Antón Ladislao A; Piñera Salmerón P; Martín Corral MJ; Gorordo Unzueta MI; Lopetegui Eraso P; García Lamberechts EJ; Quintana López JM
    Emergencias; 2019 Feb; 31(1):21-26. PubMed ID: 30656869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations.
    Cheng Y; Tu X; Pan L; Lu S; Xing M; Li L; Chen X
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2069-2074. PubMed ID: 28790809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline for the management of chronic obstructive pulmonary disease--2011 update.
    Abdool-Gaffar MS; Ambaram A; Ainslie GM; Bolliger CT; Feldman C; Geffen L; Irusen EM; Joubert J; Lalloo UG; Mabaso TT; Nyamande K; O'Brien J; Otto W; Raine R; Richards G; Smith C; Stickells D; Venter A; Visser S; Wong M;
    S Afr Med J; 2011 Jan; 101(1 Pt 2):63-73. PubMed ID: 21526617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.
    Cheng SL; Lin CH; Wang CC; Chan MC; Hsu JY; Hang LW; Perng DW; Yu CJ; Wang HC;
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):429-435. PubMed ID: 30150099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study.
    Miravitlles M; Koblizek V; Esquinas C; Milenkovic B; Barczyk A; Tkacova R; Somfay A; Zykov K; Tudoric N; Kostov K; Zbozinkova Z; Svoboda M; Sorli J; Krams A; Valipour A
    Respir Med; 2019 Apr; 150():141-148. PubMed ID: 30961941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.
    Yang IA; Brown JL; George J; Jenkins S; McDonald CF; McDonald VM; Phillips K; Smith BJ; Zwar NA; Dabscheck E
    Med J Aust; 2017 Nov; 207(10):436-442. PubMed ID: 29129177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Update on current care guideline: chronic obstructive pulmonary disease (COPD)].
    Harju T; Kankaanranta H; Katajisto M; Kilpeläinen M; Lehtimäki L; Lehto J; Mazur W; Meinander T; Peisa T
    Duodecim; 2014; 130(17):1774-6. PubMed ID: 25272791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.